DENVER, CO / ACCESSWIRE / September 12, 2016 / ClubsCorp has invited Phoenix Life Sciences, Inc. ("Phoenix Life Sciences") to be the exclusive presenter at their Investor Conference in New York City on September 15, 2016. ClubsCorp is a national network built on connecting entrepreneurs and investors.
Phoenix Life Sciences is in the final stages of completing its merger with MediJane Holdings, Inc. (OTC: MJMD) as part of creating a platform for global expansion. Ben Doherty, ClubCorp Chairman and Founder stated, "ClubsCorp sees this as the perfect time to focus its resources on positioning Phoenix Life Sciences so that it can achieve its goal for US and global expansion. We are proud to have a company of the caliber of Phoenix Life Sciences as our exclusive presenter for the New York Conference as part of their national road show. In fact, this is the first time we have a company that is strong enough to be given exclusivity in presenting to our network of investors."
Phoenix Life Sciences is preparing for a series of presentations over the coming months to profile the company, its advancements in the field of healthcare and investment opportunities.
For investor information, please contact:
Stone Tadlock,
Vice President
stone.tadlock@phoenix.life
720.575.6255
About Phoenix Life Sciences, Inc.
Phoenix Life Sciences is a healthcare solutions company. Its business is to produce and distribute products around the globe that target and treat the following seven major categories of medical conditions: pain, cancer, psychological, gastrointestinal, autoimmune, neurological, and sleep disorders. These categories include conditions that effect hundreds of millions of patients worldwide. Phoenix Life Sciences intends to build an integrated healthcare organization by creating products and programs using emerging biological products such as cannabinoid and other plant extracts. Delivering these programs through research, managed agriculture, pharmaceutical production and physician education and distribution networks.
Contact:
Phoenix Life Sciences, Inc.
Investor Relations
Phone: 720-575-6066
E-mail: info@phoenix.life
For more information, visit www.phoenix.life
About MediJane Holdings Inc. (OTC: MJMD)
MediJane Holdings, Inc. recently announced that a Letter of Intent for a reorganization and merger between MediJane and Phoenix Life Sciences has been executed. The vision of the merger is to develop an international network of production, research, testing facilities for distribution of disruptive medical solutions. Following the merger, the company will be known as Phoenix Life Sciences.
Contact
MediJane Holdings, Inc.
Investor Relations
Phone: 720-442-7242
E-mail: investor.relations@mjmd.net
About ClubsCorp Business Link
CLUBSCORP Business Link is a national membership business network and organizer of investment events focusing on the development of exclusive membership chapters within the national network. These chapters are comprised of qualified investors who are all CLUBSCORP Business Link Members such as individual accredited investors, executives of private and publicly traded companies, and other business professionals who have made their money the old-fashioned way: hard work and playing by the rules.
CLUBSCORP Business Link is an interactive platform allowing its members to connect both online through their online social business connections as well as in person at membership-chapter luncheons, all-day conferences, and international conferences & educational events.
Information contained in this press release regarding MediJane Holdings, Inc. and Phoenix Life Sciences, Inc. (the "Companies") may constitute forward-looking statements or statements which may be deemed or construed to be forward-looking statements. The words "plan", "forecast", "anticipates", "estimate", "project", "intend", "expect", "should", "believe," and similar expressions are intended to identify forward-looking statements. These forward-looking statements involve, and are subject to, known and unknown risks, uncertainties and other factors which could cause the Companies actual results, performance (financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking statements. The risks, uncertainties and other factors are more fully discussed in the Companies filings with the U.S. Securities and Exchange Commission. All forward-looking statements attributable to the Companies herein are expressly qualified in their entirety by the above-mentioned cautionary statement. The companies disclaim any obligation to update forward-looking statements contained in this press release, except as may be required by law.
SOURCE: Phoenix Life Sciences, Inc.
ReleaseID: 445136
